NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.22% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.76% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.25% |
| UCB | UCB SA | Healthcare | Biotechnology | 4.10% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.67% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.41% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 3.34% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.17% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 3.00% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 2.72% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.50% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.37% |
| MRUS | Merus BV | Healthcare | Biotechnology | 2.34% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.33% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.23% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 2.11% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.93% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 1.91% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 1.83% |